紫杉醇是一种常用于治疗乳腺癌和卵巢癌的化疗药物，但是，随着用药时间的延长，一些肿瘤可以对其产生抗药性，而又开始生长了。
Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again.
最近研究者们发现TEM1可作为与肿瘤生长相关的血管细胞的一个特异性的遗传学标记物，该发现可能有助于卵巢癌的诊断和治疗。
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.
目的探讨化疗联合放疗综合治疗晚期卵巢癌的疗效和毒性。
Objective: To study the effect and side effect of advanced ovarian cancer treated by chemotherapy combined with radiotherapy.
目的研究长春酰胺、阿克拉霉素、丝裂霉素联合化疗治疗耐药卵巢癌的疗效和毒性反应。
To study the response rate and toxic side effects of vindesine, aclarubicin and mitomycin(VAM) as a new regimen of second line chemotherapy for ovarian carcinoma.
本研究目的是探讨复发性卵巢癌治疗的意义和方法。
The purpose of the study was to evaluate treatment opportunity for patients with recurrent ovarian cancer.
结论测定卵巢癌患者血清中cea、CA125水平对了解病情、诊断、治疗和预后上是一个重要的临床参考指标。
Conclusion Serum CEA, CA125 levels are closely related to the diseases process and are of prognostic value in patients with ovarian cancer.
卵巢癌是恶性度最高的妇科肿瘤之一，由于手术和化疗的不尽人意，基因治疗是当今肿瘤研究的热点。
Ovarian cancer is one of the most malignant tumors in women. Gene therapy is the hot spot in tumor research because of the low efficiency of the operation and chemical therapy.
结论CD147反义核酸能抑制卵巢癌的转移和成瘤，因而有可能成为卵巢癌的治疗的药物靶点。
CONCLUSION CD147 antisense RNA can inhibit invasion and tumorigenesis of ovarian cancer cells and CD147 may become a new drug target of tumor therapy.
目的：初步探讨高强度聚焦超声对裸鼠卵巢癌皮下移植瘤治疗前后的超声和磁共振变化。
Objective: To study changes of ultrasound and magnetic resonance image of high intensity focused ultrasound (HIFU) in the treatment of subcutaneous ovary carcinoma of nude mice.
结论：卵巢癌治疗后1年内复发大多与临床期别较晚、手术切除不彻底和化疗疗程不足有关。
CONCLUSION: Early (1-year) recurrence in the patients with ovarian cancer seems to be closely related to late stage of the disease, incomplete surgery, and insufficient chemotherapy courses.
澳大利亚国家乳腺癌和卵巢癌防治中心称如果新的治疗方法一旦成功，将会对乳腺癌的处理推进一大步。
Australia's National breast and Ovarian cancer Center said the new procedure, if successful, would be in an important step forward in dealing with breast cancer.
BSI的- 201目前正处于第二阶段的审判，并表示治疗转移性三阴性乳腺癌，卵巢癌和其他恶性肿瘤。
BSI-201 is currently in phase-two trials and is indicated for treatment of metastatic triple negative breast cancer, ovarian cancer and other malignancies.
试验证明紫杉醇对多种癌症有疗效，但对治疗乳腺癌、卵巢癌和肺癌的效果最好。
The experiment proved the Paclitaxel has the curative effect to many kinds of cancers, furthermore it treats breast cancer, the ovarian cancer and the lung cancers effect is the best.
卵巢癌个体化治疗是根据患者的具体情况，选择适宜患者的手术和药物治疗方案，从而达到最有利于患者的治疗效果。
Individualized treatment is the optimal treatment on patient with ovarian cancer, which chose surgical and drug treatment project according to specific condition of patient.
结论卵巢癌患者的生活质量与卵巢癌分期、手术治疗和家庭月人均收入水平有关。
Conclusions The quality of life in ovarian cancer patients was related with cancer stage, operation and each person income of family per mouth.
结论卵巢癌患者的生活质量与卵巢癌分期、手术治疗和家庭月人均收入水平有关。
Conclusions The quality of life in ovarian cancer patients was related with cancer stage, operation and each person income of family per mouth.
应用推荐